Ready to play
Ready to play
A preliminary clinical trial has shown that an innovative stem cell injection resulted in a 94% reduction in the rate of osteoporotic fractures, with the fracture rate decreasing from 8 to 1 per year over two years following treatment. This marks the first time stem cell therapy has been used to combat the disease, representing a breakthrough that opens new horizons for effective osteoporosis treatment—especially for patients who do not respond to traditional medications. The results suggest that the technique aims to rebuild bones and enhance their strength, with further trials expected to confirm its efficacy and facilitate official approval of the treatment.
Notice: This Is an AI-Generated Summary
Comments (0)